Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis From Malignant Tumor of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04925063
What this trial is testing

The Effect of Metformin in Patients With Newly Diagnosed mHSPC

Who this might be right for
Metastatic Prostate Cancer
Sun Yat-sen University 266
Testing effectiveness (Phase 2)Study completedNCT00520481
What this trial is testing

Study With IMC-A12 (Cixutumumab) in Patients Who Have Not Previously Been Treated With Chemotherapy With Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the Prostate
Eli Lilly and Company 41
Early research (Phase 1)Study completedNCT01385228
What this trial is testing

Pazopanib, Docetaxel, Prednisone Prostate

Who this might be right for
Prostate Cancer
Daniel George, MD 36
Not applicableNot Yet RecruitingNCT07804030
What this trial is testing

AI-Assisted Patient Support in mHSPC

Who this might be right for
Metastatic Prostate Cancer
Fudan University 160
Not applicableUnknownNCT03876912
What this trial is testing

The Effect of ADT on PSMA Expression in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Turku University Hospital 35
Testing effectiveness (Phase 2)Study completedNCT02512458
What this trial is testing

Study of the Effect of Chemotherapy With Cabazitaxel on Prostate Cancer

Who this might be right for
Bone Metastatic Prostate Cancer
Hellenic Cooperative Oncology Group 60
Not applicableStudy completedNCT07428642
What this trial is testing

PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.

Who this might be right for
Metastatic Hormone-Sensitive Prostate CancerProstate Cancer
First Affiliated Hospital of Wenzhou Medical University 168
Large-scale testing (Phase 3)Active Not RecruitingNCT05204927
What this trial is testing

177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastasis From Malignant Tumor of Prostate
Curium US LLC 439
Testing effectiveness (Phase 2)Study completedNCT00901342
What this trial is testing

Open Label Study of Sipuleucel-T in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Dendreon 104
Large-scale testing (Phase 3)Study completedNCT05590793
What this trial is testing

Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate

Who this might be right for
Advanced Prostate CancerMetastatic Prostate CancerLocally Advanced Prostate Cancer
Ipsen 195
Not applicableNot Yet RecruitingNCT06009549
What this trial is testing

A Journey Into Participation Patterns Among Metastatic Prostate Cancer Patients

Who this might be right for
Metastatic Prostate Cancer
Power Life Sciences Inc. 500
Testing effectiveness (Phase 2)Study completedNCT01706458
What this trial is testing

Provenge With or Without pTVG-HP DNA Booster Vaccine in Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 18
Testing effectiveness (Phase 2)Study completedNCT00330161
What this trial is testing

Vorinostat in Treating Patients With Progressive Metastatic Prostate Cancer

Who this might be right for
Recurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 29
Large-scale testing (Phase 3)Study completedNCT00316927
What this trial is testing

Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
St. Bartholomew's Hospital 260
Post-approval studies (Phase 4)WithdrawnNCT00255268
What this trial is testing

CMAB vs IMAB in Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
AstraZeneca 15
Not applicableUnknownNCT01814150
What this trial is testing

The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel

Who this might be right for
Metastatic Lung CancerMetastatic Breast CancerMetastatic Gastric Cancer+2 more
Gottfried Maya 200
Testing effectiveness (Phase 2)UnknownNCT00002775
What this trial is testing

Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Herbert Irving Comprehensive Cancer Center 37
Not applicableWithdrawnNCT01274572
What this trial is testing

Blood for Immune Response to Provenge® in HRPC

Who this might be right for
Prostate Cancer
Mary Crowley Medical Research Center
Not applicableStudy completedNCT02456571
What this trial is testing

CTC Immune Checkpoint

Who this might be right for
Prostate Cancer
Duke University 38
Post-approval studies (Phase 4)Active Not RecruitingNCT06479187
What this trial is testing

PSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate Cancer

Who this might be right for
Metastatic Prostate CancerHormone Sensitive Prostate CancerMetastatic Hormone-sensitive Prostate Cancer (mHSPC)
Brigham and Women's Hospital 20
Next Page